STEMMING THE SUPERBUG TIDE. Driss Ait Ouakrim OECD Health Division

Similar documents
COST-EFFECTIVENESS OF INTERVENTIONS TO LIMIT THE SPREAD OF AMR A PERSPECTIVE FROM THE OECD

The challenge of growing resistance

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries

COPING WITH ANTIMICROBIAL RESISTANCE

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

Antimicrobial Resistance, yes we care! The European Joint Action

Antimicrobial Resistance and Dentistry. LDC Officials Day 4 December 2015 Susie Sanderson

AMR situation in Europe: Strategy and vision

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

EU strategy to fight against Antimicrobial Resistance

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

Antimicrobial Resistance Update for Community Health Services

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe

Council of the European Union Brussels, 13 June 2016 (OR. en)

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer

Evaluation of EU strategy to combat AMR

IFMSA Policy Proposal Antimicrobial Resistance

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Antimicrobial resistance (AMR): action plans implementation. Kamil Saytkulov February, Moscow

Antimicrobial Stewardship. Where are we now and where do we need to go?

24th EUROPEAN IAIDO CHAMPIONSHIPS Torino (ITA) - November 4th, 2017

ANTIMICROBIAL RESISTANCE AND NATIONAL ACTION PLAN FOR PRUDENT USE OF ANTIMICROBIALS Egypt, GOVS 2017

2016/LSIF/FOR/004 Policies to Promote Patient Access to Innovative Treatments and Combat Antimicrobial Resistance

Pan-Canadian Action Plan on Antimicrobial Resistance and Antimicrobial Use

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune

National Action Plan development support tools

WORLD ANTIBIOTIC AWARENESS WEEK

Stratégie et action européennes

Summary of the latest data on antibiotic consumption in the European Union

Lessons learned from the AMR program in Thailand. 29 May 2014

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

ANTIMICROBIAL RESISTANCE

Perspective on AnA Global timicrobial Resistance

AMR in AFRICA. Dr Marc Sprenger Director AMR Secretariat. Antimicrobial resistance in Africa

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Introduction to antimicrobial resistance

ANTIMICROBIAL RESISTANCE: GLOBAL BURDEN

Reduction of Antibiotics in poultry meat production. Dutch action plan. Ben Dellaert Director Avined Buenos Aires, 27th October 2016

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

Jaipur Declaration on Antimicrobial Resistance

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

Anne Santerre Henriksen- Florence February 17th

COMMISSION OF THE EUROPEAN COMMUNITIES

Stratégies et actions au niveau européen et international: populations humaines

RESPONSIBLE 39.36% 82% 91% CHAIRMAN S MESSAGE USE OF ANTIBIOTICS BANNED

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017

TACKLING ANTIMICROBIAL RESISTANCE ENSURING SUSTAINABLE R&D

Global action plan to combat antimicrobial resistance (AMR)

Highlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan)

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

Antimicrobial Resistance Prevention (Action Package: Prevent-1) Putting AMR on the priority list: Sweden Dr. Nils Anders Tegnell, Director, The

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

Surveillance of AMR in PHE: a multidisciplinary,

AMR epidemiological situation: ECDC update

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

JETTRIBE EUROPEAN JETSKI CHAMPIONSHIP - POLAND - JULY 13-17,2016 PRO-AM SKI VETERANS GP

Consultation on a draft Global action plan to address antimicrobial resistance

STRICTLY EMBARGOED UNTIL 00:01 GMT, 22 MARCH 2016

The Philippine Action Plan to Combat Antibiotic Resistance: One Health Approach

IFMSA Policy Proposal [Antimicrobial Resistance]

Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass

Prudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia

Consultation on a draft Global action plan to address antimicrobial resistance

EU Research on Antimicrobial drug resistance Anna Lönnroth Sjödén Unit Infectious Diseases, Directorate Health DG Research European Commission

WELSH HEALTH CIRCULAR

Antibiotic Resistance A Major Threat to the Sustainable Development Goals

Overview of Canada's Federal Actions to Address Antimicrobial Resistance and Antibiotic Stewardship

Options for a global development and stewardship framework to combat AMR Consultation of Member States and relevant partners

Impact of NHS England Quality Indicators on Antimicrobial Resistance. Professor Alan Johnson National Infection Service Public Health England

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

Clinical and Economic Impact of Urinary Tract Infections Caused by Escherichia coli Resistant Isolates

2016/LSIF/FOR/003 Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated Infections Antimicrobial Resistance

Actions for combatting Antimicrobial Resistance (AMR)

& chicken. Antibiotic Resistance

Antimicrobial Stewardship: The South African Perspective

Antimicrobial Stewardship Northern Ireland

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

European challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012

The European AMR Challenge - strategic views from the human perspective -

The role of FAO in AMR

DANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals

Global Action Plan on Antimicrobial Resistance

Antibiotic Stewardship in Human Health- Progress and Opportunities

Combating Antimicrobial Resistance: A Manufacturing Perspective

ANTIMICROBIAL STEWARDSHIP IN PRIMARY CARE DR ROSEMARY IKRAM MBBS FRCPA CLINICAL MICROBIOLOGIST

German Antimicrobial Resistance Strategy DART 2020

Infection control and antimicrobial resistance in Republic of Moldova. Riga, May 6-8, 2015

Epidemiology and Economics of Antibiotic Resistance

WHO perspective on antimicrobial resistance

Averting the AMR crisis

WHO's View on IVDs for Addressing AMR

Transcription:

STEMMING THE SUPERBUG TIDE Driss Ait Ouakrim OECD Health Division

Prevalence rate (%) AMR Will Keep Increasing If No Effective Actions Are Put in Place Resistance proportions for eight antibiotic-bacterium combinations in the OECD 45 40 35 30 25 20 15 10 5 0 2005 2015 2030

Antimicrobial resistance index [2005 = 100] among selected bug-drug combinations Resistance to 2 nd and 3 rd line Treatments Will Grow the Most 200 OECD countries 200 G20 countries 175 150 2 nd -line 175 150 3 rd -line 2 nd -line 125 100 3 rd -line 125 100 1 st -line 1 st -line 75 2005 2010 2015 2020 2025 2030 75 2005 2010 2015 2020 2025 2030

Average yearly cost of AMR per capita (USD PPP) Health and economic burden of AMR 67 000 deaths per year 3.5B USD PPPs per year 7 6 5 4 3 2 2.14 1 0

Health and economic burden of AMR Deaths per 100 000 people Annual cost per 100 000 people (thousand USD) An average of 94 persons die each year in Slovenia due to infections from eight resistant bacteria. By 2050, an estimated total of 16 000 persons will die due to AMR. Annual cost of AMR: $4.4 million By 2050, health care costs in Slovenia could reach $143 million

Number of countries Only 9 OECD Countries Have Developed and Fund a One-health AMR Action Plan 20 18 16 14 12 10 8 6 4 2 0 No national AMR action plan SVN ROU POL* HUN GRC EST BGR BRA National AMR action plan under development TUR SVK PRT PER MEX MLT ISR CZE CYP COL CHL* CAN National AMR action plan developed CHE ESP ZAF RUS NZL LTU LVA ITA IRL IDN IND DEU FRA FIN DNK BEL AUT AUS ARG National AMR action plan approved by government that reflects Global Action Plan objectives, with an operational plan and monitoring arrangements USA GBR SWE SAU KOR NOR NLD LUX JPN ISL HRV CHN National AMR action plan has funding sources identified, is being implemented, involves relevant sectors and has a defined monitoring and evaluation process

Policy Approaches to Tackle Irrational Use of Antimicrobials Delayed prescriptions Mass media campaigns Stewardship programmes Enhanced environm. hygiene Improved hand hygiene RDTs in GP practices Key aspects Up to 3 days post-dated prescription Education purposes while providing sense of safety Different approaches Messages delivered by major mass media (TV, radio, journals, etc.) Yearly waves cantered on the winter season Educational/ behavioural interventions for physicians; Decision aid tools Implementati on of advanced cleaning techniques (e.g. no touch) Training support Culturechange program on the WHO-5 campaign Cleaning facilities available at the point of care Training for healthcare personnel Early identification of viral/bacter. infections and of AMR Reimburseme nt of test to GP, incentive to use, info for patients Effects in literature 63% filled-in prescriptions 6.5% antibiotic consumption 40% antibiotic prescription 24-68% AMR 26% - 49% hospitalacquired infections 48% hospitalacquired infections 22% antibiotic consumption

Avoided deaths per year Public Health Policies to Tackle AMR Save Lives 0 Improved hand hygiene Stewardship program Enhanced environmental Rapid hygiene diagnostic tests Delayed prescription Mass media campaigns -10,000-20,000-30,000-40,000 EU-28 & EEA US & Canada Australia

Yearly cost per 1,000 persons (USD/PPPs) And Decrease Healthcare Expenditure 450 Decrease in annual hospital costs caused by infections 300 150 0-150 -300-450 Improved hand hygiene Stewardship programmes Implementation cost Enhanced environemental hygiene Rapid diagnostic tests Delayed prescriptions Savings in healthcare expenditure Mass media campaigns Note: columns show the median value across 33 OECD and EU countries; whiskers show min and max values

Average probability across countries Tackling AMR is a Very Good Investment for OECD and EU Countries 100% 80% 60% 40% 20% 0% Improved hand hygiene Delayed prescription Stewardship program Rapid diagnostic tests Enhanced environmental hygiene Mass media campaigns Cost-saving CE ratio>50 000 USD PPP/DALY CE ratio<50 000 USD PPP/DALY Inferior to business as usual

Effects of individual AMR control policies in Slovenia

A 4-Pronged Approach is Needed to Steam the Superbug Tide Stewardship programmes to promote prudent use of antibiotics and end decades of over-prescription Enhanced hygiene in healthcare settings to minimize cross-patient transmission of resistant and susceptible infections mixed-intervention package Mass media campaigns to make people aware of the risks associated with imprudent use of antibiotics Rapid diagnostic tests to detect whether an infection requires antibiotics or not, in primary care settings

A Mixed Intervention Package Would Save up To 47000 Lives per Year in OECD and EU Slovenia: 77

Net savings per capita (USD PPP) A Mixed Intervention Package Would Decrease Healthcare Expenditure by 3 USD/Capita/Year 0-2 -4-2.70-6 -8-10 -12

Key Policy Implications AMR is increasing in the majority of OECD countries and beyond The projected rise in resistance to 2 nd and 3 rd line antibiotics is particularly worrisome Interventions to increase hygiene show the most positive effects but do not address some of the key determinants of AMR Public health interventions to tackle AMR are a costeffective (and very often cost-saving) investment in OECD countries Combining interventions in a comprehensive public health package would provide better results